2-neopentylisoquinolin-1(2H)-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 2-neopentylisoquinolin-1(2H)-one
• 英文别名: 2-(2,2-Dimethylpropyl)-1(2h)-isoquinolinone；2-(2,2-dimethylpropyl)isoquinolin-1-one
• 化学式: C₁₄H₁₇NO
• 分子量: 215.295
• InChiKey: PYLZFUYWVMUNIG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-neopentylisoquinolin-1(2H)-one 在 silver trifluoromethanesulfonate 、 碘 、 potassium hydroxide 作用下， 以 乙醚 为溶剂， 反应 2.0h， 以73%的产率得到4-iodo-2-neopentylisoquinolin-1(2H)-one
  参考文献：
  名称：

  Discovery of Isoquinolinone Indole Acetic Acids as Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases

  摘要：

  Previously we reported the discovery of CRA-898 (1), a diazine indole acetic acid containing CRTH2 antagonist. This compound had good in vitro and in vivo potency, low rates of metabolism, moderate permeability, and good oral bioavailability in rodents. However, it showed low oral exposure in nonrodent safety species (dogs and monkeys). In the current paper, we wish to report our efforts to understand and improve the poor PK in nonrodents and development of a new isoquinolinone subseries that led to identification of a new development candidate, CRA-680 (44). This compound was efficacious in both a house dust mouse model of allergic lung inflammation (40 mg/kg qd) as well as a guinea pig allergen challenge model of lung inflammation (20 mg/kg bid).

  DOI：

  10.1021/jm401509e
• 作为产物：
  描述：

  1-溴-2,2-二甲基丙烷 、 1-羟基异喹啉 在 caesium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 以57%的产率得到2-neopentylisoquinolin-1(2H)-one
  参考文献：
  名称：

  Discovery of Isoquinolinone Indole Acetic Acids as Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases

  摘要：

  Previously we reported the discovery of CRA-898 (1), a diazine indole acetic acid containing CRTH2 antagonist. This compound had good in vitro and in vivo potency, low rates of metabolism, moderate permeability, and good oral bioavailability in rodents. However, it showed low oral exposure in nonrodent safety species (dogs and monkeys). In the current paper, we wish to report our efforts to understand and improve the poor PK in nonrodents and development of a new isoquinolinone subseries that led to identification of a new development candidate, CRA-680 (44). This compound was efficacious in both a house dust mouse model of allergic lung inflammation (40 mg/kg qd) as well as a guinea pig allergen challenge model of lung inflammation (20 mg/kg bid).

  DOI：

  10.1021/jm401509e

文献信息

• INDOLE BASED RECEPTOR CRTH2 ANTAGONISTS
  申请人：Kaila Neelu

  公开号：US20110105509A1

  公开（公告）日：2011-05-05

  Disclosed are compounds of Formula (I): which are useful as antagonists of the CRTH2 receptors. Pharmaceutical compositions containing compounds of Formula (I) and the use of compounds of Formula (I) to treat diseases or disorders that are responsive to inhibition of the binding of endogenous ligands to the CRTH2 receptor are also disclosed. Methods for preparing and using these compounds are further described.

  公开的是以下化合物的结构（I）：这些化合物可用作CRTH2受体的拮抗剂。还公开了含有化合物（I）的药物组合物以及利用化合物（I）治疗对抑制内源配体与CRTH2受体结合响应的疾病或疾病的用途。进一步描述了制备和使用这些化合物的方法。
• Selectivity of N- Versus O-Alkylation in Mitsunobu Reactions with Various Quinolinols and Isoquinolinols
  作者：Ryan E. Hartung、Mark C. Wall、Sylvain Lebreton、Martin Smrcina、Marcel Patek

  DOI：10.3987/com-17-13710

  日期：——

  equilibria that allows systems of this nature to react as ambident nucleophiles through the conjugate base resonance structures, often leading to mixtures of Oand N-alkylation. However, like with 2-pyridones, we observed that many factors can influence the alkylation ratio. These include, but are not limited to, solvation of the nucleophile (conjugate base of the heterocycle), the electrophilicity of the activated

  除了通常所需的 O-烷基化结构外，在 Mitsunobu 条件下使喹啉醇和异喹啉醇反应可以产生 N-烷基化产物。深入研究了溶剂、试剂当量、喹啉/异喹啉氮的位置以及所用的反应脂肪醇类型如何影响 N 与 O-烷基化的比率。多年来，Mitsunobu 反应已在化学界的许多支架上使用，并已成为多个评论的主题。一种感兴趣的支架是 2-吡啶酮（方案 1），它类似于喹啉和异喹啉亚结构。然而，关于在光信条件下喹啉醇和异喹啉醇的 Nversus O-烷基化的深入研究尚未发表。由于 Mitsunobu 反应主要用于 O-烷基化，了解改变反应条件如何影响 Nor O-烷基化结果将是有益的。与在 2-吡啶酮中观察到的互变异构一样，喹啉酮和异喹啉酮（或喹啉醇和异喹啉醇，为了清楚起见，它们将在整个论文中提及）包含与其简化前体相同的互变异构特征，如方案 1 所示。2 的互变异构平衡β-羟基吡啶被证明取决于溶剂极性，在极
• Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
  申请人：Ares Trading S.A.

  公开号：US20140364396A1

  公开（公告）日：2014-12-11

  The present invention provides compounds of Formula (I) as inhibitors of LMP7 for the treatment of autoimmune and inflammatory diseases.

  本发明提供了化合物(I)的公式，作为LMP7的抑制剂，用于治疗自身免疫和炎症性疾病。
• US9688702B2
  申请人：——

  公开号：US9688702B2

  公开（公告）日：2017-06-27
• Discovery of Isoquinolinone Indole Acetic Acids as Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases
  作者：Neelu Kaila、Bruce Follows、Louis Leung、Jennifer Thomason、Adrian Huang、Alessandro Moretto、Kristin Janz、Michael Lowe、Tarek S. Mansour、Cedric Hubeau、Karen Page、Paul Morgan、Susan Fish、Xin Xu、Cara Williams、Eddine Saiah

  DOI：10.1021/jm401509e

  日期：2014.2.27

  Previously we reported the discovery of CRA-898 (1), a diazine indole acetic acid containing CRTH2 antagonist. This compound had good in vitro and in vivo potency, low rates of metabolism, moderate permeability, and good oral bioavailability in rodents. However, it showed low oral exposure in nonrodent safety species (dogs and monkeys). In the current paper, we wish to report our efforts to understand and improve the poor PK in nonrodents and development of a new isoquinolinone subseries that led to identification of a new development candidate, CRA-680 (44). This compound was efficacious in both a house dust mouse model of allergic lung inflammation (40 mg/kg qd) as well as a guinea pig allergen challenge model of lung inflammation (20 mg/kg bid).